This Opioid Alternative Is Fueling an Addiction Crisis

Kratom, an herbal product derived from Southeast Asian trees, has become a multi-billion dollar, largely unregulated industry in the United States. While many users, including chronic pain sufferers, rely on it as a safer alternative to opioids, public health officials and grieving parents warn of its addictive potential and association with thousands of fatal overdoses. The debate centers on whether the substance should be banned, particularly as newer, highly concentrated synthetic versions like 7-OH emerge. Local governments are increasingly enacting bans due to the lack of federal regulation and limited scientific research on its health impacts and potential interactions with other medications. The American Kratom Association continues to lobby for consumer protection standards, while the DEA considers stricter scheduling for potent derivatives, highlighting the ongoing tension between accessibility for pain management and public safety concerns.